CAS: 607742-69-8; 3-(Phenylsulfonyl)-8-(Piperazin-1-yl)Quinoline

该化合物是一个化学化合物,主要因其潜在的治疗应用,特别是在治疗阿尔茨海默氏病等认知障碍方面,受到调查;它作为5-HT6血清素受体的选择性敌体,它涉及各种...

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

piperazine 8-iodo-3-(phenylsulfonyl)quinoline 8-fluoro-3-(phenylsulfonyl)quinoline 8-chloro-3-(phenylsulfonyl)quinoline11C)LuPET(11C)LuPET 8-{4-[(4-fluorophenyl)sulfonyl]piperazin-1-yl}-3-(phenylsulfonyl)quinoline 8-{4-[(2-fluorophenyl)sulfonyl]piperazin-1-yl}-3-(phenylsulfonyl)quinoline

合成工艺路线路线简述

    📜Intepirdine中间体置于三氟乙酸体系中,用 二氯甲烷 作为反应溶剂,化学反应 2.0H,反应生成 3-苯磺酰基-8-(哌嗪-1-基)喹啉
    参考文献:Syntheses,Radiolabelings,And In Vitro Evaluations Of Fluorinated Pet Radioligands Of 5-Ht6 Serotoninergic Receptors
    标题:Syntheses,Radiolabelings,And In Vitro Evaluations Of Fluorinated Pet Radioligands Of 5-Ht6 Serotoninergic Receptors
    摘要:The 5-Ht6 Receptors Are Potent Therapeutic Targets For Psychiatric And Neurological Diseases (Schizophrenia,Alzheimer'S Disease,Etc.). However,With Lack Of Specific Radiopharmaceuticals,Their Pharmacology Is Still Incomplete And Their Exploration Is Limited To Animal Models. In This Context,We Have Designed A Fluorinated Pet Radiotracer,[f-18]2Fnq1P,That Possesses A High Affinity And Selectivity For 5-Ht6. In Vitro Pet Autoradiographies In Rat Brain Sections With This Radiotracer Were In Accordance With The 5-Ht6 Distribution Pattern.
    DOI:10.1021/jm500372E

    海关参考信息

    专利信息


    专利号:US-2008255359-A1
    优先权日:2005-09-28
    标题:Novel Chemical Process For the Synthesis of Quinoline Compounds
    发明人:WADE CHARLES EDWARD
    权利人:WADE CHARLES EDWARD
    摘要:Disclosed is a novel, simplified and economic process for making 3-phenylsulphonyl quinolines with an amine group at position 8 of the quinoline ring system, including 3-phenylsulfonyl-8-piperazin-1-yl-quinoline in particular, in the absence of a palladium catalyst. Also disclosed is the crystallization of polymorphic forms of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline.

    专利号:EP-1928832-A1
    优先权日:2005-09-28
    标 题 :Novel chemical process for the synthesis of quinoline compounds

    专利号:WO-2007039238-A1
    优先权日:2005-09-28
    标题 :Novel chemical process for the synthesis of quinoline compounds

    专利号:US-9676772-B2
    优先权日:2013-07-25
    标题 :Pyrroloquinoline derivatives as 5-HT6 antagonists, preparation method and use thereof
    发明人:ZAJDEL PAWEL; GRYCHOWSKA KATARZYNA; PAWLOWSKI MACIEJ; PARTYKA ANNA; WESOLOWSKA ANNA; BOJARSKI ANDRZEJ J; POPIK PIOTR; KOS TOMASZ; SATALA GRZEGORZ; LAMATY FREDERIC; COLACINO EVELINA; MARTINEZ JEAN; SUBRA GILLES; BANTREIL XAVIER
    权利人:CENTRE NAT RECH SCIENT; UNIV MONTPELLIER; UNIV JAGIELLONSKI; INST FARMAKOLOGII POLSKIEJ AKADEMII NAUK; Uniwersyter Jagiellonski
    摘要:This invention concerns pyrroloquinoline derivatives as antagonists of 5-HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in schizophrenia, anxiety, depression, maniac depression, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, panic attacks, attention deficit hyperactivity disorder, attention deficit disorder, Parkinson's disease, Huntington's disease, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, obesity and type-2 diabetes, functional bowel disorder, Irritable Bowel Syndrome. The compounds have the general formula (XIV), wherein the symbols have the meanings given in the description.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm5003759
    摘要:Krogsgaard-Larsen N, Jensen AA, Schrøder TJ, Christoffersen CT, Kehler J. Novel Aza-analogous Ergoline Derived Scaffolds as Potent Serotonin 5-HT6 and Dopamine D2 Receptor Ligands. J. Med. Chem. 2014 Jun 18;57(13):5823–8. doi: 10.1021/jm5003759.
    参考文献:10.1007/s40120-018-0095-y
    摘要:Andrews M, Tousi B, Sabbagh MN. 5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress. Neurology and Therapy. 2018 May 02;7(1):51–8. doi: 10.1007/s40120-018-0095-y.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知